january 8 50_conference drug interaction
TRANSCRIPT
-
8/2/2019 January 8 50_Conference Drug Interaction
1/21
DRUG INTERACTIONS
Guided by
Mr.pavan
Presented by
G.nandiniRoll-no
01709014
-
8/2/2019 January 8 50_Conference Drug Interaction
2/21
Drug interaction
Drug interaction can be defined as themodifications of the effects of one drug by the prior
or concomitant of another drug
The potential drug interactions has been
observed to be 17% in surgical patients, 22% in
patients in medical wards, 23% in out patients
clinics.
-
8/2/2019 January 8 50_Conference Drug Interaction
3/21
1 in 107 1 in 106 1 in 105 1 in 104 1 in 103 1 in 102
Lightning
Plane crash Murder
Auto-cash
Fatal, unexpected
drug reaction
Increasing risk of death
-
8/2/2019 January 8 50_Conference Drug Interaction
4/21
Mechanism of drug interaction
Pharmacokinetic interactions Absorption
Distribution
Biotransformation***
Excretion
Pharmacodynamic interactions Receptor interaction
Receptor sensitivity
Drug transportation
Electrolyte balance
Physiological interactions
Pharmaceutical interactions
-
8/2/2019 January 8 50_Conference Drug Interaction
5/21
Absorption interactions
Where the absorption are the object drug is altered
The net effect of such an interaction is:
Faster or slower drug absorption
More,or,less complete drug absorption
-
8/2/2019 January 8 50_Conference Drug Interaction
6/21
The distribution pattren of the object drug is altered
The major mechanism for distribution interaction is alteration is
protein
drug binding
Distribution interaction
-
8/2/2019 January 8 50_Conference Drug Interaction
7/21
Drug metabolism interaction
Enzyme inducers :increase metabolism ofconcomitant drug therefor increase drug
elimination and decrease drug effect
Barbiturate, Rifampin, Phenytoin
Enzyme inhibitors : decresae metabolism
of concomitant drug therefor decrease drugexcretion and increase drug effect
Cimetidine, Ketoconazole, Erythromycin
-
8/2/2019 January 8 50_Conference Drug Interaction
8/21
Excretion interaction
The excretion pattren of the object drug is altered
Major mechanism of excretion interactions are-
Alteration in renal flood flow
Alteration of urine pH
-
8/2/2019 January 8 50_Conference Drug Interaction
9/21
Pharmacodynamic interactions
Receptor interaction
Competitive
Non-competitive Sensitivity of receptor
Number of receptor
Affinity of receptor
Drug transportation
Electrolyte balance
-
8/2/2019 January 8 50_Conference Drug Interaction
10/21
Physiological interactions
Drug A and Drug B bind to different receptors onthe same tissue but give opposite or similar
effect
Aspirin (anti-platelet)+Warfarin/Coumarin (anticoagulant)
Increase bleeding
-
8/2/2019 January 8 50_Conference Drug Interaction
11/21
Pharmaceutical interactions
Chemical or physiological interactions
Vitamin C + amphotericin B Pennicilin + Vitamin C
-
8/2/2019 January 8 50_Conference Drug Interaction
12/21
Drug-Drug interaction may alter drug effect by
Additive effect : 1 + 1 =2
Synergistic effect : 1 +1 > 2
Potentiation effect : 1 + 0 =2
Antagonism : 1-1 = 0
-
8/2/2019 January 8 50_Conference Drug Interaction
13/21
Drug-Food interactions
Grape seed and cyclosporin
Grape seed and felodipine
-
8/2/2019 January 8 50_Conference Drug Interaction
14/21
Drug-Herb interactions
Ginko biloba
-
8/2/2019 January 8 50_Conference Drug Interaction
15/21
St. Johns wort: CYP3A4 inducer
-
8/2/2019 January 8 50_Conference Drug Interaction
16/21
Drug features associated with potentialinteractions
Narrow therapeutic index :
Phenytoin
Cyclosporine
TheophyllineSharp response curve:
Phenytoin
Aminoglycoside
VancomycinDose dependent (Michaelis-Menten) kinetic
Phenytoin
-
8/2/2019 January 8 50_Conference Drug Interaction
17/21
List of drug the most commoninteracting drug
Antacids
Cimetidine
Digoxin
Warfarin
Theophylline
Ketoconazole
-
8/2/2019 January 8 50_Conference Drug Interaction
18/21
Problem in medical practice
Possible reasonsPhysiological factors Pathological factors Food
Drug interactionGenetic
D t bl t
-
8/2/2019 January 8 50_Conference Drug Interaction
19/21
i
Drug tablet
Drug in blood
Drug in tissues
Drug at receptor
Drug metabolites Drug in urine/bil
Desired response No response Unwanted response
Drug interaction
Release
Drug in gut
Absorption
Distribution
Pharmacokinetics
Pharmacodynamics
-
8/2/2019 January 8 50_Conference Drug Interaction
20/21
CONCLUSION
TodayDrug A
Drug B
Drug CDrug D
Individual physician experience
Cost: time, money & well-being
FuturePatient genetic
s profiles
Drug ADrug B
Drug CDrug D
Informed physician diagnosisSaving : time, money & patients life
-
8/2/2019 January 8 50_Conference Drug Interaction
21/21
REFERENCES
D.M. BRAHMANKAR
SATHOSKAR
The George Mateljan
Fellers PJ, Nikdel S, Lee HS
K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF
J. Thomas
A. David Rodrigues
Barrie R. Cassileth, Charles D. Lucarelli